Chargement en cours...
Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
BACKGROUND: Unresectable gastric cancer is associated with poor outcomes, with few treatment options available after failure of cytotoxic chemotherapy. Clinical trials of targeted therapies have generally shown no survival benefit in gastric cancer, with the exceptions of the antibodies ramucirumab...
Enregistré dans:
| Publié dans: | J Exp Clin Cancer Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625870/ https://ncbi.nlm.nih.gov/pubmed/26514182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0243-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|